Neuren jumps 11pc on US patent win
Mid-cap pharma stock Neuren has jumped almost 11 per cent after announcing that the United States Patent and Trademark Office has allowed its patent application for a treatment of Pitt Hopkins syndrome (PTHS).
There are currently no approved treatments for PTHS, which has a severely debilitating impact on the lives of patients, the company said in a statement to the ASX on Thursday before the market opened.
55 mins ago – 11.15AMNeuren jumps 11pc on US patent winGus...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.31 |
Change
0.770(6.14%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $12.96 | $14.00 | $12.91 | $19.76M | 1.453M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $13.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.33 | 3716 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |